Systemic medical management of diabetic retinopathy.

Middle East Afr J Ophthalmol · 2013 · PMC3841947 · PMID 24339679

Europe PMC DOI

hedged sentence

0.0508

closest p · 1.0× alpha

0.0508

boldest claim

The sentences

marginally significantP = 0.0508so close (0.05 < p ≤ 0.1)

The prevent-1 that studied the role of this drug in preventing diabetic retinopathy in type 1 diabetics and Protect-1 and Protect-2 that studied the effect of the drug in halting the progression of diabetic retinopathy in type 1 and type 2 diabetes, respectively.[ 23 24 ] Treatment with Candesartan was able to reduce the incidence of retinopathy by 18% (a marginally significant achievement P = 0.0508).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.